Tonix Pharmaceuticals Holding Corp. Quarterly report pursuant to Section 13 or 15(d)

FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($) $ in Thousands	Sep. 30, 2018	Dec. 31, 2017
Fair Value, Measurements, Recurring [Member] \| Quoted Prices In Active Markets (Level 1) [Member] \| Cash Equivalents [Member]
Total assets	$ 12,500	$ 17,300